{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:59:03Z","timestamp":1790402343320,"version":"4.1.0"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T00:00:00Z","timestamp":1451520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1005316","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T18:39:37Z","timestamp":1451587177000},"page":"e1005316","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication"],"prefix":"10.1371","volume":"11","author":[{"given":"Sarah","family":"Knowlson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Burlison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Macadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Minor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,31]]},"reference":[{"key":"ref1","unstructured":"WHO (2015); http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek.aspx<\/ext-link> (Accessed 14th August 2015)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1099\/vir.0.036988-0","article-title":"The polio eradication programme and issues of the endgame","volume":"93","author":"PD Minor","year":"2012","journal-title":"J Gen Virol"},{"key":"ref3","unstructured":"WHO(2014a): Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines(inactivated);http:\/\/www.who.int\/biologicals\/vaccines\/Annex3_IPV_Recommendations_eng.pdf?ua=1<\/ext-link>(accessed 14th August 2015)"},{"key":"ref4","unstructured":"WHO(2014b). Polio eradication and end game strategic plan. (2015)http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Resources\/StrategyWork\/PEESP_EN_A4.pdf<\/ext-link> (accessed August 18th 2015)"},{"key":"ref5","article-title":"Global action plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of OPV use","year":"2014"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/434699a","article-title":"A global call for new polio vaccines","volume":"434","author":"DL Heymann","year":"2005","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1128\/JVI.00370-06","article-title":"Rational design of genetically stable, live attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication","volume":"80","author":"AJ Macadam","year":"2006","journal-title":"J. Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0166-0934(93)90022-J","article-title":"Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro","volume":"41","author":"P. A. Pipkin","year":"1993","journal-title":"J.Virol.Methods"},{"key":"ref9","unstructured":"WHO (2014d). Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (oral, live, attenuated) ECBS 63rd report; TRS 980, 51\u2013140 http:\/\/www.who.int\/biologicals\/WHO_TRS_980_WEB.pdf?ua=1<\/ext-link> (accessed August 14th 2015)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/viro.2000.0244","article-title":"Coding changes in the poliovirus protease 2A compensate for 5'NCR domain V disruptions in a cell-specific manner","volume":"269","author":"A. Rowe","year":"2000","journal-title":"Virology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/vir.0.19088-0","article-title":"Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains","volume":"84","author":"J. Martin","year":"2003","journal-title":"J.Gen.Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0092-1157(89)90004-8","article-title":"Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies","volume":"17","author":"C Singer","year":"1989","journal-title":"J. Biol. Stand"},{"key":"ref13","first-page":"119","article-title":"Potency testing of killed polio vaccine in rats","volume":"47","author":"G. van Steenis","year":"1981","journal-title":"Dev Biol Stand"},{"key":"ref14","article-title":"Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan","author":"H Shimizu","year":"2014","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.123.3209.1151","article-title":"Pathogenesis of poliomyelitis: reappraisal in the light of new data","volume":"123","author":"A.B Sabin","year":"1956","journal-title":"Science"},{"key":"ref16","first-page":"370","article-title":"Live attenuated vaccines: historical successes and current challenges","volume":"479\u2013480","author":"PD Minor","year":"2015","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0042-6822(92)90565-7","article-title":"Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture","volume":"189","author":"A. J. Macadam","year":"1992","journal-title":"Virology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/JVI.65.10.5225-5231.1991","article-title":"An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain","volume":"65","author":"A. J. Macadam","year":"1991","journal-title":"J.Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/JVI.63.3.1338-1344.1989","article-title":"Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine","volume":"63","author":"G. D. Westrop","year":"1989","journal-title":"J.Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1073\/pnas.83.8.2330","article-title":"Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase","volume":"83","author":"S. van der Werf","year":"1986","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1005316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T12:25:06Z","timestamp":1599999906000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1005316"}},"subtitle":[],"editor":[{"given":"Vincent","family":"Racaniello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,31]]},"references-count":20,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1005316","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,31]]}}}